Page last updated: 2024-11-08

triiodothyronine and Coma, Hyperglycemic Hyperosmolar Nonketotic

triiodothyronine has been researched along with Coma, Hyperglycemic Hyperosmolar Nonketotic in 1 studies

Triiodothyronine: A T3 thyroid hormone normally synthesized and secreted by the thyroid gland in much smaller quantities than thyroxine (T4). Most T3 is derived from peripheral monodeiodination of T4 at the 5' position of the outer ring of the iodothyronine nucleus. The hormone finally delivered and used by the tissues is mainly T3.
3,3',5-triiodo-L-thyronine : An iodothyronine compound having iodo substituents at the 3-, 3'- and 5-positions. Although some is produced in the thyroid, most of the 3,3',5-triiodo-L-thyronine in the body is generated by mono-deiodination of L-thyroxine in the peripheral tissues. Its metabolic activity is about 3 to 5 times that of L-thyroxine. The sodium salt is used in the treatment of hypothyroidism.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Spyridoulias, A1
Riaz, MS1

Other Studies

1 other study available for triiodothyronine and Coma, Hyperglycemic Hyperosmolar Nonketotic

ArticleYear
Myxoedema coma in the setting of hyperglycaemic hyperosmolar state.
    BMJ case reports, 2016, Jan-11, Volume: 2016

    Topics: Female; Humans; Hyperglycemic Hyperosmolar Nonketotic Coma; Hypoglycemic Agents; Hypotension; Hypoth

2016